CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 2017—The U.S. Department of Health and Human Services announced that Siemens Healthineers has been awarded $8.9 million by the Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and Development Authority to advance the development of a Zika assay for use on the company’s Advia Centaur XPT, Advia Centaur XP, and Advia Centaur CP immunoassay systems for the clinical laboratory. The company anticipates the assay will also be developed for its next-generation Atellica Solution system.
The assay will be developed to detect IgM antibodies specific to the Zika virus.
Siemens Healthineers, 888-826-9702